STAT3 and sarcoma: JAK2-STAT3 inhibitor treatment of these sarcoma cells led to downregulation of pSTAT3 and growth inhibition, indicating this type of inhibitor presents a potential treatment for leiomyosarcomas (Additional file 1: Figure.